Bridgeway Capital Management, LLC Pulmonx Corp Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 62,900 shares of LUNG stock, worth $438,413. This represents 0.01% of its overall portfolio holdings.
Number of Shares
62,900
Previous 68,300
7.91%
Holding current value
$438,413
Previous $566,000
24.56%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$38.4 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$21.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$15.9 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$10.7 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $260M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...